Cited by 1,625COVID-19 Clinical Research StudiesRespiratory Support and MechanismsSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Open access

Geleris, Joshua, Sun, Yifei, Platt, Jonathan, Zucker, Jason, Baldwin, Matthew, Hripcsak, George, Labella, Angelena, Manson, Daniel K., Kubin, Christine, Barr, R. Graham, Sobieszczyk, Magdalena E., Schluger, Neil W.·2020·New England Journal of Medicine

DOI 10.1056/nejmoa2012410PMC PMC7224609

Open this paper in CoChat — free account

Abstract

BACKGROUND: Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. METHODS: We examined the association between hydroxychloroquine use and intubation or death at a large medical center in New York City. Data were obtained regarding consecutive patients hospitalized with Covid-19, excluding those who were intubated, died, or discharged within 24 hours after presentation to the emergency department (study baseline). The primary end point was a composite of intubation or death in a time-to-event analysis. We compared outcomes in patients who received hydroxychloroquine with those in patients who did not, using a multivariable Cox model with inverse probability weighting according to the propensity score. RESULTS: Of 1446 consecutive patients, 70 patients were intubated, died, or discharged within 24 hours after presentation and were excluded from the analysis. Of the remaining 1376 patients, during a median follow-up of 22.5 days, 811 (58.9%) received hydroxychloroquine (600 mg twice on day 1, then 400 mg daily for a median of 5 days); 45.8% of the patients were treated within 24 hours after presentation to the emergency department, and 85.9% within 48 hours. Hydroxychloroquine-treated patients were more severely ill at baseline than those who did not receive hydroxychloroquine (median ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen, 223 vs. 360). Overall, 346 patients (25.1%) had a primary end-point event (180 patients were intubated, of whom 66 subsequently died, and 166 died without intubation). In the main analysis, there was no significant association between hydroxychloroquine use and intubation or death (hazard ratio, 1.04, 95% confidence interval, 0.82 to 1.32). Results were similar in multiple sensitivity analyses. CONCLUSIONS: In this observational study involving patients with Covid-19 who had been admitted to the hospital, hydroxychloroquine administration was not associated with either a greatly lowered or an increased risk of the composite end point of intubation or death. Randomized, controlled trials of hydroxychloroquine in patients with Covid-19 are needed. (Funded by the National Institutes of Health.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa2012410

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Retracted
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L. Y., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,696
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Devaux, C. A., Rolain, J., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,122
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trialPreprint
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 861
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D. F., Song, S., Zhang, D., et al. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.03.03 · Cited by 662
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Fantini, J., Scala, C. D., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105960 · Cited by 566
Mechanism of action of hydroxychloroquine as an antirheumatic drug
Fox, R. I. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(10)80012-5 · Cited by 430
Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities
Biot, C., Daher, W., Leleu‐Chavain, N., Fandeur, T., Khalife, J., Dive, D., & Clercq, E. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 318

Show all 17 references

Sorted by citations

Items 601–700 of 1,000

Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study.
Ashinyo, M. E., Duti, V., Dubik, S. D., Amegah, K. E., Kutsoati, S., Oduro‐Mensah, E., Puplampu, P., Gyansa‐Lutterodt, M., Darko, D. M., Buabeng, K. O., et al. (2020) · PubMed Central · doi:10.11604/pamj.supp.2020.37.9.25718 · Cited by 21
Twitter in Brazil: Discourses on China in Times of Coronavirus
de Andrade, F. M. R., Barreto, T. B., Feligreras, A. H., Ugolini, A., & Lu, Y. (2020) · Social Sciences & Humanities Open · doi:10.1016/j.ssaho.2021.100118 · Cited by 21
Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
Mendez, S. R., Frank, R. C., Stevenson, E. K., Chung, M., & Silverman, M. G. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.073 · Cited by 21
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician
Tleyjeh, I. M., Kashour, T. S., Mandrekar, J. N., & Petitti, D. B. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab317 · Cited by 21
Emerging therapies for COVID-19 pneumonia
Battaglini, D., Robba, C., Ball, L., Cruz, F. F., Silva, P. L., Pelosi, P. P., & Rocco, P. R. M. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1771694 · Cited by 21
An observational cohort study of hydroxychloroquine and azithromycin for COVID-19: (Can’t Get No) Satisfaction
Lee, T. C., MacKenzie, L. J., McDonald, E. G., & Tong, S. Y. C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.095 · Cited by 21
Real-World Effectiveness of Hydroxychloroquine, Azithromycin, and Ivermectin Among Hospitalized COVID-19 Patients: Results of a Target Trial Emulation Using Observational Data from a Nationwide Healthcare System in PeruPreprint
Soto-Becerra, P., Culquichicón, C., Hurtado-Roca, Y., & Araujo-Castillo, R. V. (2020) · medRxiv · doi:10.1101/2020.10.06.20208066 · Cited by 21
Efficacy of various treatment modalities for nCOV‐2019: A systematic review and meta‐analysis
Misra, S., Nath, M., Hadda, V., & Vibha, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13383 · Cited by 20
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience
Caraffa, R., Bagozzi, L., Fiocco, A., Bifulco, O., Nadali, M., Ponzoni, M., Carrozzini, M., Toscano, G., Fraiese, A. P., Metra, M., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa323 · Cited by 20
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
Law, M. F., Ho, R., Law, K. W. T., & Cheung, C. K. M. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i12.1850 · Cited by 21
A nomogram model for predicting 5-year risk of prediabetes in Chinese adults
Hu, Y., Han, Y. Y., Liu, Y., Cui, Y., Ni, Z., Wei, L., Cao, C., Hu, H., & He, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-50122-3 · Cited by 20
Hydroxychloroquine for treatment of nonsevere COVID‐19 patients: Systematic review and meta‐analysis of controlled clinical trials
Elsawah, H. K., Elsokary, M. A., Elrazzaz, M., & Elshafie, A. H. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26442 · Cited by 20
Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance
Rodrigues, C., Freitas-Santos, R. S., Levi, J. E., Senerchia, A. A., Lopes, A. T. A., dos Santos, S. R., Siciliano, R. F., & Pierrotti, L. C. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106428 · Cited by 20
Neural connectome prospectively encodes the risk of post-traumatic stress disorder (PTSD) symptom during the COVID-19 pandemic
Chen, Z., Feng, P., Becker, B., Xu, T., Nassar, M. R., Sirois, F. M., Hommel, B., Zhang, C., He, Q., Qiu, J., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100378 · Cited by 20
An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
Cao, H., Yang, S., Wang, Y., Luan, N., Yin, X., Lin, K., & Liu, C. (2021) · Vaccines · doi:10.3390/vaccines9111261 · Cited by 20
Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians
Qaseem, A., Yost, J., Etxeandia‐Ikobaltzeta, I., Miller, M. C., Abraham, G. M., Obley, A. J., Forciea, M. A., Jokela, J. A., & Humphrey, L. L. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3862 · Cited by 20
Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses Via Hypothesized Alleviation of CD147-Mediated Vascular OcclusionPreprint
Scheim, D. E. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3636557 · Cited by 20
The first wave of COVID-19 in Malta; a national cross-sectional study
Micallef, S., Piscopo, T. V., Casha, R., Borg, D., Vella, C., Zammit, M. A., Borg, J., Mallia, D., Farrugia, J., Vella, S. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239389 · Cited by 19
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
Güner, R., Hasanoğlu, İ., Kayaaslan, B., Aypak, A., Akıncı, E., Bodur, H., Eser, F., Kalem, A. K., Küçükşahin, O., Ateş, İ., et al. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.12.017 · Cited by 19
Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis
Abdelrahman, Z., Liu, Q., Jiang, S., Li, M., Sun, Q., Zhang, Y., & Wang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.607408 · Cited by 19
Aligning Medical and Muslim Morality: An Islamic Bioethical Approach to Applying and Rationing Life Sustaining Ventilators in the COVID-19 Pandemic Era
Padela, A. I., Ali, M., & Yusuf, A. (2021) · Journal of Islamic Ethics · doi:10.1163/24685542-12340061 · Cited by 19
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients
Gómez, R. I., Méndez, R., Palanques-Pastor, T., Ballesta‐López, O., Almenar, C. B., Megías‐Vericat, J. E., Briz, E. L., Font-Noguera, I., Menéndez, R., Iborra, J. A. R., et al. (2021) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2021-002741 · Cited by 19
Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study
Lin, K., Wei, F., Huang, Q., Lai, Z., Zhang, J., Chen, Q., Jiang, Y., Kong, J., Tang, S., Lin, J., et al. (2022) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s352480 · Cited by 19
Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study
Reino-Gelardo, S., Palop-Cervera, M., Aparisi-Valero, N., Miguel, I. E.-S., Lozano, N., Furquet, G. L., Artero, L. S., Cortés-Castell, E., Baeza, M. R., & Cortés, X. (2023) · Nutrients · doi:10.3390/nu15071736 · Cited by 19
The link between initial cardiac rhythm and survival outcomes in in-hospital cardiac arrest using propensity score matching, adjustment, and weighting
Han, Y. Y., Hu, H., Shao, Y., Deng, Z., & Liu, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-58468-y · Cited by 19
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports
Prasad, A., Panhwar, M. S., Hendel, R. C., Sheikh, O., Mushtaq, Z., Dollar, F., Vinas, A., Alraies, M. C., Almonani, A., Nguyen, T. H., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.06.009 · Cited by 18
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
Rihani, S. B. A., Smith, M. K., Bikmetov, R., Deodhar, M., Dow, P., Turgeon, J., & Michaud, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082591 · Cited by 19
Electrocardiographic Changes and Arrhythmias in Hospitalized Patients With COVID-19
Moey, M., Sengodan, P. M., Shah, N. N., McCallen, J., Eboh, O., Nekkanti, R., Carabello, B. A., & Naniwadekar, A. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009023 · Cited by 19
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
Özsürekçi, Y., Oygar, P. D., Gürlevik, S. L., Kesici, S., Özen, S., Şükür, E. D. K., Gülhan, B., Topaloğlu, R., Bayrakçı, B., & Cengiz, A. B. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05111-x · Cited by 19
The nature, cause and consequence of COVID-19 panic among social media users in India
Bhattacharya, C., Chowdhury, D., Ahmed, N., Özgür, S., Bhattacharya, B., Mridha, S. K., & Bhattacharyya, M. (2021) · Social Network Analysis and Mining · doi:10.1007/s13278-021-00750-2 · Cited by 19
Maternal exposure to hydroxychloroquine and birth defects
Howley, M. M., Werler, M. M., Fisher, S. C., Zutphen, A. R. V., Carmichael, S. L., Broussard, C. S., Heinke, D., Ailes, E. C., Pruitt, S., Reefhuis, J., et al. (2021) · Birth Defects Research · doi:10.1002/bdr2.1943 · Cited by 19
Twitter and Facebook posts about COVID-19 are less likely to spread false and low-credibility content compared to other health topicsPreprint
Broniatowski, D. A., Kerchner, D., Farooq, F., Huang, X., Jamison, A., Dredze, M. H., & Quinn, S. C. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.09682 · Cited by 19
Hydroxychloroquine and azithromycin as a treatment of COVID-19
(GrAM), G. D. A. M., Fanin, A., Calegari, J. G., Beverina, A., & Tiraboschi, S. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02388-y · Cited by 18
Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena
Samaddar, A., Grover, M., & Nag, V. L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585888 · Cited by 18
Reducing SARS-CoV-2 pathological protein activity with small molecules
Pluskota‐Karwatka, D., Hoffmann, M., & Barciszewski, J. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.012 · Cited by 18
Adapting for the COVID-19 pandemic in Ecuador, a characterization of hospital strategies and patients
Garzón-Chávez, D., Romero-Álvarez, D., Bonifaz, M., Gaviria, J., Mero, D., Gunsha, N., Perez, A., Garcia, M., Espejo, H., Espinosa, F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251295 · Cited by 18
Characteristics, outcomes and global trends of respiratory support in patients hospitalized with COVID-19 pneumonia: a scoping review
Radovanovic, D., Santus, P., Coppola, S., Saad, M., Pini, S., Giuliani, F., Mondoni, M., & Chiumello, D. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.21.15486-0 · Cited by 18
Integrating Human-in-the-loop into Swarm Learning for Decentralized Fake News Detection
Dong, X., Sarker, S., & Qian, L. (2022) · International Conference on Intelligent Data Science Technologies and Applications (IDSTA) · doi:10.1109/idsta55301.2022.9923043 · Cited by 18
Evaluating the Influence of Role-Playing Prompts on ChatGPT’s Misinformation Detection Accuracy: Quantitative Study
Haupt, M. R., Yang, L., Purnat, T. D., & Mackey, T. K. (2024) · JMIR Infodemiology · doi:10.2196/60678 · Cited by 18
Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction
Kazi, D. S., Martin, L. M., Litmanovich, D. E., Pinto, D. S., Clerkin, K. J., ZIMETBAUM, P. J., & Dudzinski, D. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmcpc2002417 · Cited by 18
COVID-19: therapeutic approaches description and discussion
TRINDADE, G. G., Caxito, S. M. C., Xavier, A. R. E. O., Xavier, M. A. D. S., & Brandão, F. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200466 · Cited by 18
Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19
Ahsan, W., Alhazmi, H. A., Patel, K., Mangla, B., Bratty, M. A., Javed, S., Najmi, A., Sultan, M. H., Makeen, H. A., Khalid, A., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00384 · Cited by 18
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic
Alsayegh, F., & Mousa, S. A. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620955240 · Cited by 18
SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management
Mihăescu, G., Chifiriuc, M. C., Iliescu, C., Vrâncianu, C. O., Diţu, L.-M., Marutescu, L. G., Grigore, R., Bertesteanu, S. V., Constantin, M., & Pîrcălăbioru, G. G. (2020) · Microorganisms · doi:10.3390/microorganisms8101468 · Cited by 18
C4 article: Implications of COVID-19 in transplantation
article, C. T. T. C. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16346 · Cited by 18
Clinical management of Lupus patients during the COVID-19 pandemic
Mason, A., Rose, E., & Edwards, C. J. (2020) · Lupus · doi:10.1177/0961203320961848 · Cited by 18
Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System
Randhawa, P. K., Scanlon, K. R., Rappaport, J., & Gupta, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.611275 · Cited by 18
Global COVID ‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system
Dörks, M., Jobski, K., Hoffmann, F., & Douros, A. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5217 · Cited by 18
The time is now: role of pragmatic clinical trials in guiding response to global pandemics
Almufleh, A. S., & Joseph, J. (2021) · Trials · doi:10.1186/s13063-021-05165-0 · Cited by 18
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
Mokhtari, M., Mohraz, M., Gouya, M. M., Tabar, H. N., Tabrizi, J. S., Tayeri, K., Aghamohamadi, S., Rajabpoor, Z., Karami, M., Raeisi, A., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107636 · Cited by 18
Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review
Starshinova, A. A., Malkova, A. M., Zinchenko, Y. S., Kudlay, D. A., Glushkova, A. V., Dovgalyk, I., Yаblonskiy, P. K., & Shoenfeld, Y. (2021) · Life · doi:10.3390/life11080753 · Cited by 18
Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach
Kumar, D. T., Devi, M. S. S., Kumar, S. U., Sherlin, A., Mathew, A., Lakshmipriya, M., Parameswaran, S., Ramanathan, G., Siva, R., Magesh, R., et al. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.007 · Cited by 18
Modeling the Effect of Population-Wide Vaccination on the Evolution of COVID-19 Epidemic in CanadaPreprint
Berkane, S., Harizi, I., & Tayebi, A. (2021) · medRxiv · doi:10.1101/2021.02.05.21250572 · Cited by 18
Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis
Zang, Y., Han, X., He, M., Shi, J. C., & Li, Y. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01964-5 · Cited by 17
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
Abu-Raya, B., Migliori, G. B., O’Ryan, M., Edwards, K. M., Torres, A., Alffenaar, J. C., Märtson, A., Centis, R., D’Ambrosio, L., Flanagan, K. L., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.572485 · Cited by 17
Photo-mediated and advanced oxidative processes applied for the treatment of effluents with drugs used for the treatment of early COVID-19: Review
Albornoz, L. L., Soroka, V. D., & Silva, M. C. A. (2021) · Environmental Advances · doi:10.1016/j.envadv.2021.100140 · Cited by 17
COVID-19 fatality rates in hospitalized patients: A new systematic review and meta-analysis
Baptista, A., Vieira, A. M., Capela, E., Julião, P. L., & Macedo, A. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.07.006 · Cited by 17
Coronavirus Disease 2019 (COVID-19) – An Overview
Bashera, A., Das, D., & Faiz, M. (2020) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v38i0.47513 · Cited by 17
Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
Acharya, Y., & Sayed, A. (2020) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120947517 · Cited by 17
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Aljabali, A. A. A., Bakshi, H. A., Satija, S., Metha, M., Prasher, P., Ennab, R. M., Chellappan, D. K., Gupta, G., Negi, P., Goyal, R., et al. (2020) · Pharmaceutical Nanotechnology · doi:10.2174/2211738508999200817163335 · Cited by 17
Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review
Levett, J. Y., Raparelli, V., Mardigyan, V., & Eisenberg, M. J. (2020) · CJC Open · doi:10.1016/j.cjco.2020.09.003 · Cited by 17
An effective drug against COVID-19: reality or dream?
Yaghoubi, A., Jamehdar, S. A., Movaqar, A., Milani, N., & Soleimanpour, S. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1854092 · Cited by 17
COVID-19: The experience from Iran
Daneshpazhooh, M., & Mahmoudi, H. (2020) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2020.12.009 · Cited by 17
Gender differences in treatment of Coronavirus Disease-2019
Ambrosino, I., Barbagelata, E., Corbi, G., Ciarambino, T., Politi, C., & Moretti, A. M. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1508 · Cited by 17
Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma
Sok, V., Marzan, F., Gingrich, D. J., Aweeka, F. T., & Huang, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247356 · Cited by 17
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19
Robba, C., Battaglini, D., Ball, L., Pelosi, P. P., & Rocco, P. R. M. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1906226 · Cited by 17
Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
Firestone, T. M., Oyewole, O. O., Reid, S. P., & Ng, C. L. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00222 · Cited by 17
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
Lo, C.-H., Wang, Y., Tsai, C., Chan, K., Li, L.-C., Lo, T.-H., Wei, J. C., & Su, C.-H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251918 · Cited by 17
Polymeric surfaces with biocidal action: challenges imposed by the SARS-CoV-2, technologies employed, and future perspectives
de Castro, K. C., & Costa, J. M. (2021) · Journal of Polymer Research · doi:10.1007/s10965-021-02548-4 · Cited by 17
A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19
Mashayekhi‐Sardoo, H., & Hosseinjani, H. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0495 · Cited by 17
High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study
Vecchié, A., Batticciotto, A., Tangianu, F., Bonaventura, A., Pennella, B., Abenante, A., Corso, R., Grazioli, S., Mumoli, N., Para, O., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02800-1 · Cited by 17
Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach
Dhankhar, P., Dalal, V., & Kumar, V. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2020.0639 · Cited by 17
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Dumache, R., Enache, A., Macasoi, I. G., Dehelean, C. A., Dumitrascu, V. C., Mihailescu, A., Popescu, R., Vlad, M., Vlad, C. S., & Mureşan, C. O. (2022) · Pathogens · doi:10.3390/pathogens11050516 · Cited by 17
Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis
Xie, X., Hu, L., Xue, H., Xiong, Y., Panayi, A. C., Lin, Z., Chen, L., Yan, C., Zhou, W., Mi, B., et al. (2022) · Acta Materia Medica · doi:10.15212/amm-2022-0002 · Cited by 17
Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers
de Reus, Y. A., Hagedoorn, P., Sturkenboom, M. G. G., Grasmeijer, F., Bolhuis, M. S., Sibum, I., Kerstjens, H. A. M., Frijlink, H. W., & Akkerman, O. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272034 · Cited by 17
What the HIV Pandemic Experience Can Teach the United States About the COVID-19 Response
Strathdee, S. A., Martin, N. K., Pitpitan, E. V., Stockman, J. K., & Smith, D. M. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002520 · Cited by 17
Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19Preprint
Sales-Medina, D. F., Ferreira, L. R. P., Romera, L. M. D., Gonçalves, K. R., Guido, R. V. C., Courtemanche, G., Buckeridge, M. S., Durigon, E. L., Moraes, C. B., & Freitas-Junior, L. H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.196337 · Cited by 17
Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in MadridPreprint
Bernaola, N., Mena, R., Bernaola, A., Carballo, C., Lara, A., Bielza, C., & Larrañaga, P. (2020) · medRxiv · doi:10.1101/2020.07.17.20155960 · Cited by 17
What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden
Cardoso, C. R. D. B., Fernandes, A. P., & Santos, I. K. F. D. M. (2020) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0713-2020 · Cited by 17
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal
El-Hachem, N., Eid, E. S., Nemer, G. M., Dbaibo, G. S., Abbas, O. M., Rubeiz, N., Zeineldine, S. M., Matar, G. M., Bikorimana, J., Shammaa, R., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101697 · Cited by 16
Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
Hoertel, N., Rico, M. S., Gulbins, E., Kornhuber, J., Vernet, R., Beeker, N., Neuraz, A., Blanco, C., Olfson, M., Airagnes, G., et al. (2022) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000743 · Cited by 16
Association of estimated glomerular filtration rate and incident pre-diabetes: A secondary 5-year longitudinal cohort study in Chinese people
Wang, X., Huang, C., Liu, Y., Han, Y. Y., & Hu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965545 · Cited by 16
Hydroxychloroquine Retinal Toxicity
Proano, C. E., & KIMBALL, G. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmicm1304542 · Cited by 16
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time
Davido, B., Boussaïd, G., Vaugier, I., Lansaman, T., Bouchand, F., Lawrence, C., Alvarez, J., Moine, P., Perronne, V., Barbot, F., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106129 · Cited by 16
Medicare expenditures for conventional and biologic disease modifying agents commonly used for treatment of rheumatoid arthritis
Dalal, D. S., Zhang, T., & Shireman, T. I. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.08.002 · Cited by 16
Antivirals for COVID-19 in Solid Organ Transplant Recipients
Laracy, J. C., Verna, E. C., & Pereira, M. R. (2020) · Current Transplantation Reports · doi:10.1007/s40472-020-00304-z · Cited by 16
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
Vomero, M., Barbati, C., Colasanti, T., Celia, A. I., Speziali, M., Ucci, F. M., Ciancarella, C., Conti, F., & Alessandri, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.569849 · Cited by 16
The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19
Alexandrova, R., Beykov, P., Vassilev, D. I., Jukič, M., & Podlipnik, Č. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1847683 · Cited by 16
Covid-19: The Biggest Threat of the 21st Century: In Respectful Memory of the Warriors All Over the World
Karcıoğlu, O., Yüksel, A., Baha, A., Er, A. B., Esendagli, D. R., Gülhan, P. Y., Karaoğlanoğlu, S., Erçelik, M., Şerifoğlu, İ., Yıldız, E., et al. (2020) · Turkish Thoracic Journal · doi:10.5152/turkthoracj.2020.20069 · Cited by 16
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options
Rebold, N., Holger, D. J., Alosaimy, S., Morrisette, T., & Rybak, M. J. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00399-6 · Cited by 16
Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
Lamback, E. B., de Oliveira, M. A., Haddad, A. F., Vieira, A. F. M., Neto, A. L. F., Maia, T. D. S., Chrisman, J. D. R., Spineti, P. P. D. M., de Mattos, M. A., & Costa, E. (2021) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2021.101549 · Cited by 16
Clinical characteristics of older patients with COVID-19: a systematic review of case reports
Córdova, L. D. S., Mayor-Vega, A., Luján-Carpio, E., Parodi, J. F., Moncada–Mapelli, E., Armacanqui-Valencia, I., Salvador-Ruiz, J., Pawer, D., Ydrogo-Cruz, E., Chevarría-Arriaga, M. J., et al. (2021) · Dementia & Neuropsychologia · doi:10.1590/1980-57642021dn15-010001 · Cited by 16
Ongoing COVID-19 Pandemic: A Concise but Updated Comprehensive Review
Wang, C., Xiao, X., Feng, H., Hong, Z., Li, M., Tu, N., Li, X., Wang, K., & Bu, L. (2021) · Current Microbiology · doi:10.1007/s00284-021-02413-z · Cited by 16
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Yanagida, S., Satsuka, A., Hayashi, S., Ono, A., & Kanda, Y. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab079 · Cited by 16
Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review
Pandey, R., Rai, D., Tahir, M., Wahab, A., Bandyopadhyay, D., Lesho, E. P., Laguio-Vila, M. R., Fentanes, E., Tariq, R., Naidu, S. S., et al. (2022) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2022.115008 · Cited by 16
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale
Schluger, N. W. (2020) · Annals of Internal Medicine · doi:10.7326/m20-5041 · Cited by 16
Self-citation
Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)”
VIu, M., Orlova, Y. A., Павликова, Е. П., Мацкеплишвили, С. Т., Akopyan, Z. A., Геннадьевна, П. А., Seredenina, E. M., Asratyan, D. A., Potapenko, A. V., Малахов, П. С., et al. (2020) · Kardiologiia · doi:10.18087/cardio.2020.8.n1307 · Cited by 15
Pharmacological management of COVID-19 in type 2 diabetes
Ceriello, A., & Prattichizzo, F. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107927 · Cited by 15
Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses
Sun, Q., Li, X., & Kuang, E. (2022) · Autophagy · doi:10.1080/15548627.2022.2116677 · Cited by 15
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients
Lü, K., Wu, Y.-M., Shi, Q., Gong, Y.-Q., Zhang, T., & Li, C. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06905-5 · Cited by 15

Authors: Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., Sobieszczyk, M. E., & Schluger, N. W.
Affiliations: Columbia University Irving Medical Center (US)
Corresponding author: Schluger, Neil W.
ORCID: Geleris, Joshua
Sun, Yifei
Platt, Jonathan
Zucker, Jason
Baldwin, Matthew
Hripcsak, George
Manson, Daniel K.
Kubin, Christine
Barr, R. Graham
Sobieszczyk, Magdalena E.
Schluger, Neil W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-06-18
Volume: 382
Issue: 25
Pages: 2411-2418
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa2012410
PMC: PMC7224609
OpenAlex: W3023346879
Cited by: 1,625
References: 17
Citations by year: 2026: 16 · 2025: 23 · 2024: 57 · 2023: 80 · 2022: 167 · 2021: 440 · 2020: 839
FWCI: 49.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (RO1-HL077612, RO1-HL093081, RO1-HL121270, RO1-LM006910)
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (200-2009-32593)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: hydroxychloroquine, COVID-19 pandemic, mechanical ventilation, intubation, mortality, hospitalized patients, antimalarial drugs, treatment efficacy, propensity score weighting, SARS-CoV-2
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Adult, Aged, Aged, 80 and over, Female, Hospitalization, Humans, Hydroxychloroquine, Intubation, Male, Middle Aged, New York City, Pneumonia, Viral, Treatment Failure, Coronavirus Infections, Propensity Score, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks